Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting

By Bonafede Machaon   Johnson Barbara H.   Fox Kathleen M.   Watson Crystal   Gandra Shravanthi R.  

Journal of Dermatological Treatment, Vol. 24, Iss. 5, 2013-10 ,pp. : 369-373

Informa Healthcare

Access to resources Recommend Favorite

Paradoxical worsening of psoriasis when switching from etanercept to adalimumab: A case series

By Bhutani Tina   Koo John  

Journal of Dermatological Treatment, Vol. 22, Iss. 2, 2011-04 ,pp. : 75-78

Informa Healthcare

Access to resources Recommend Favorite

Economic evaluation of biologic therapies for the treatment of moderate to severe psoriasis in the United States

By Anis Aslam H.   Bansback Nick   Sizto Sonia   Gupta Shiraz R.   Willian Mary K.   Feldman Steve R.  

Journal of Dermatological Treatment, Vol. 22, Iss. 2, 2011-04 ,pp. : 65-74

Informa Healthcare

Access to resources Recommend Favorite

ILVEN: Is it Psoriasis? Debate Based on Successful Treatment with Etanercept

By Renner Regina   Colsman Andreas   Sticherling Michael  

Acta Dermato-Venereologica, Vol. 88, Iss. 6, 2008-11 ,pp. : 631-632

Medical Journals Limited

Access to resources Recommend Favorite

Adalimumab treatment is associated with improvement in health-related quality of life in psoriasis: Patient-reported outcomes from a Phase II randomized controlled trial

By Shikiar Richard   Heffernan Michael   Langley Richard   Willian Mary   Okun Martin   Revicki Dennis  

Journal of Dermatological Treatment, Vol. 18, Iss. 1, 2007-01 ,pp. : 25-31

Informa Healthcare

Access to resources Recommend Favorite